5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Cochlear Hearing Loss in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dossena, S | 1 |
| Vezzoli, V | 1 |
| Cerutti, N | 1 |
| Bazzini, C | 1 |
| Tosco, M | 1 |
| Sironi, C | 1 |
| Rodighiero, S | 1 |
| Meyer, G | 1 |
| Fascio, U | 1 |
| Fürst, J | 1 |
| Ritter, M | 1 |
| Fugazzola, L | 1 |
| Persani, L | 1 |
| Zorowka, P | 1 |
| Storelli, C | 1 |
| Beck-Peccoz, P | 1 |
| Bottà, G | 1 |
| Paulmichl, M | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Cochlear Hearing Loss
| Article | Year |
|---|---|
Functional characterization of wild-type and a mutated form of SLC26A4 identified in a patient with Pendred syndrome.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Biological Transport; Cells, Cultured; Chlorides; | 2006 |